Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. (Nasdaq: PWUP) is a biopharmaceutical-focused entity that originated as a blank-check special purpose acquisition company targeting the life sciences and biopharma sector. The company filed an 8-K with the SEC on May 28, 2024, under accession number 0001493152-24-021628, signaling a material corporate development in its SPAC lifecycle. PWUP operates within the healthcare and biopharmaceutical industry vertical, reflecting continued SPAC activity in the life sciences space. The filing marks a notable milestone in the vehicle's progression from initial public offering through its post-combination phase. For complete filings history, sponsor details, deal timelines, and live SPAC metrics on PWUP and thousands of other vehicles, sign up for full data access at SpacDesk.